report-pharmaceutical sector study

8/11/2019 Report-Pharmaceutical Sector Study

1/92


2/92


3/92


4/92


5/92


6/92
http://apps.who.int/nha/database


7/92


8/92


9/92


10/92


11/92


12/92
http://compendium.iift.ac.in/


13/92


14/92


15/92


16/92


17/92


18/92


19/92


20/92


21/92


22/92


23/92


24/92


25/92


26/92


27/92


28/92


29/92


30/92


31/92


32/92


33/92


34/92


35/92


36/92


37/92


38/92


39/92


40/92


41/92
http://www.pharmatimes.com/Article/12-12-24


42/92


43/92


44/92


45/92


46/92


47/92


48/92


49/92


50/92


51/92


52/92


53/92


54/92


55/92


56/92
http://www.cci.gov.in/May2011/OrderOfCommission/CaseNo29of2010MainOrder.pdf


57/92


58/92


59/92


60/92


61/92


62/92


63/92


64/92


65/92


66/92


67/92


68/92


69/92


70/92


71/92


72/92


73/92


74/92


75/92


76/92


77/92
http://www.business-standard.com/india/prof_page.php?search=Dasatinib&select=1http://www.business-standard.com/india/prof_page.php?search=Ixabepilone&select=1http://www.business-standard.com/india/prof_page.php?search=Trastuzumab&select=1


78/92


79/92


80/92


81/92
http://www.commerce.nic.in/traderemedies/ad_casesinindia.asp?id=2http://www.wto.org/english/tratop_e/adp_e/adp_e.htm


82/92


83/92
http://www.cci.gov.in/May2011/OrderOfCommission/OrderKanzania110511.pdfhttp://www.cci.gov.in/menu/YSMalik110211.pdfhttp://www.cci.gov.in/menu/YSMalik110211.pdfhttp://www.cci.gov.in/menu/YSMalik110211.pdfhttp://www.cci.gov.in/menu/CSRNanjing110211.pdfhttp://www.cci.gov.in/menu/CCA16.pdfhttp://www.cci.gov.in/menu/CCA16.pdfhttp://www.cci.gov.in/menu/CCA16.pdf


84/92


85/92


86/92


87/92


88/92


89/92
http://www.epw.in/epw/uploads/articles/15116.pdf


90/92


91/92
http://planningcommission.nic.in/aboutus/committee/wrkgrp12/wg_pharma2902.pdf


92/92

report-pharmaceutical sector study

Documents